Team

Dr. Andreas Herrmann

Founder

<div class="frame-space-before-medium"></div><div id="c28" class="frame frame-default frame-type-text frame-layout-0"><p><strong>Dr. Andreas Herrmann</strong> founded Probiocon based on his more than 25 years of experience gained in biotechnological companies, where he was holding different management positions and was engaged as consultant.</p><p>From 2013–2016, Andreas built up Alvotech, a leading biosimilars company based in Iceland with a 4 product pipeline and 14,000 sqm manufacturing plant and made 2 successful acquisitions and other strategic initiatives. Between 2003-2013, Andreas (co-)founded and headed different biotech companies including <strong>Celonic </strong>(CMO), <strong>Baliopharm </strong>(innovator company for autoimmune diseases, oncology), <strong>Synimmune </strong>(bispecific antibodies, oncology), <strong>ICAAN </strong>(Aesthetic Navigation), and<strong> Icelandic Natura </strong>(Topica). In 1996 Andreas co-founded <strong>Cardion&nbsp;</strong>where he was heading the R&amp;D department until 2003. As part of the management team he was responsible for fund raising as well as the CMC and preclinical development of biopharmaceutical compounds, up to final licensing of the lead compound to Roche. He received his Ph.D. in biochemistry in the field of neurobiology and worked as an associate professor in the department of cardiovascular physiology at the University of Cologne (1995-1997).</p><p>During his career, Andreas served as a consultant for many pharma and venture companies e.g. <strong>Roche</strong>, <strong>Glycothera</strong>, <strong>JRS</strong>, <strong>TVM</strong>, <strong>Centus Capital </strong>and others.</p><p>&nbsp;</p><p><strong>Andreas has main expertise in the following areas:</strong></p><p>&nbsp;</p><ul><li>Business development</li><li>Merger &amp; acquisitions</li><li>Due diligence</li><li>Licensing / partnering</li><li>Alliance &amp; portfolio management</li><li>Corporate finance incl. fundraising</li><li>Development / manufacturing of biopharmaceutical compounds</li><li>Quality assurance / regulatory compliance</li></ul></div>

We use cookies to improve your user experience. By continuing to browse the site you are giving your consent for us to set cookies. If you don't agree, you can find here further informations.

OK, I agree.